A Multicenter phase 1/1b open label dose escalation study of ABT-165 a dual variable domain immunoglobin in subject with advanced solid tumors.
Clinical Trial Grant
Awarded By
AbbVie Inc.
Start Date
November 1, 2013
End Date
November 1, 2023
Awarded By
AbbVie Inc.
Start Date
November 1, 2013
End Date
November 1, 2023